Free Trial

3M (MMM) Financials

3M logo
$146.30 +0.08 (+0.06%)
Closing price 05/15/2026 03:59 PM Eastern
Extended Trading
$145.30 -1.00 (-0.69%)
As of 08:05 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for 3M

Annual Income Statements for 3M

This table shows 3M's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
4,833 5,050 4,858 5,349 4,517 5,449 5,921 5,777 -6,995 4,173 3,250
Consolidated Net Income / (Loss)
4,841 5,058 4,869 5,363 4,529 5,453 5,929 5,791 -6,979 4,188 3,262
Net Income / (Loss) Continuing Operations
4,841 5,058 4,869 5,363 4,529 5,458 5,919 4,016 -8,404 4,015 3,210
Total Pre-Tax Income
6,823 7,053 7,548 7,000 5,643 6,795 7,204 4,204 -11,271 4,819 4,213
Total Operating Income
6,946 7,027 7,692 7,207 6,174 7,161 7,369 4,369 -10,689 4,822 4,629
Total Gross Profit
14,891 14,991 15,602 16,083 15,000 15,579 16,560 10,308 9,627 10,128 9,957
Total Revenue
30,274 30,109 31,657 32,765 32,136 32,184 35,355 26,161 24,610 24,575 24,948
Operating Revenue
30,274 30,109 31,657 32,765 32,136 32,184 35,355 26,161 24,610 24,575 24,948
Total Cost of Revenue
15,383 15,118 16,055 16,682 17,136 16,605 18,795 15,853 14,983 14,447 14,991
Operating Cost of Revenue
15,383 15,118 16,055 16,682 17,136 16,605 18,795 15,853 14,983 14,447 14,991
Total Operating Expenses
7,992 7,964 7,910 8,876 8,826 8,418 9,191 5,939 20,316 5,306 5,328
Selling, General & Admin Expense
6,229 6,311 6,626 7,602 7,029 6,929 7,197 7,232 19,198 4,221 3,997
Research & Development Expense
1,763 1,764 1,870 1,821 1,911 1,878 1,994 1,160 1,154 1,085 1,169
Restructuring Charge
-47 - - - - - 0.00 -2,724 -36 0.00 162
Total Other Income / (Expense), net
-123 26 -144 -207 -531 -366 -165 -165 -582 -3.00 -416
Income Tax Expense
1,982 1,995 2,679 1,637 1,114 1,337 1,285 188 -2,867 804 1,003
Net Income / (Loss) Discontinued Operations
- - - - - - - 1,764 1,407 164 0.00
Other Adjustments to Consolidated Net Income / (Loss)
- - - - 0.00 - 10 11 18 9.00 52
Net Income / (Loss) Attributable to Noncontrolling Interest
8.00 8.00 11 14 12 4.00 8.00 14 16 15 12
Basic Earnings per Share
$7.72 $8.35 $8.13 $9.09 $7.83 $9.43 $10.23 $10.21 ($12.63) $7.58 $6.05
Weighted Average Basic Shares Outstanding
625.60M 604.70M 597.50M 588.50M 577M 577.60M 579M 566M 553.90M 550.80M 537.40M
Diluted Earnings per Share
$7.58 $8.16 $7.93 $8.89 $7.72 $9.36 $10.12 $10.18 ($12.63) $7.55 $6.00
Weighted Average Diluted Shares Outstanding
637.20M 618.70M 612.70M 602M 585.10M 582.20M 585.30M 567.60M 553.90M 552.40M 541.30M
Weighted Average Basic & Diluted Shares Outstanding
625.60M 604.70M 597.50M 588.50M 575.60M 579.10M 571.10M 550.50M 552.70M 542.90M 526.70M
Cash Dividends to Common per Share
$4.10 $4.44 $4.70 $5.44 $5.76 $5.88 $5.92 $5.96 $6.00 $3.61 $2.92

Quarterly Income Statements for 3M

This table shows 3M's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders
-2,075 945 928 1,145 1,372 728 1,116 723 834 577 653
Consolidated Net Income / (Loss)
-2,071 947 933 1,151 1,376 728 1,122 725 841 574 659
Net Income / (Loss) Continuing Operations
-2,525 311 709 1,207 1,373 503 1,120 678 839 573 657
Total Pre-Tax Income
-3,302 272 929 1,410 1,721 451 1,385 923 1,147 758 878
Total Operating Income
-3,096 524 1,149 1,272 1,316 733 1,246 1,140 1,447 796 1,397
Total Gross Profit
2,554 1,100 2,531 2,684 2,647 1,123 2,476 2,698 2,725 2,058 2,456
Total Revenue
6,270 4,026 6,016 6,255 6,294 4,023 5,954 6,344 6,517 6,133 6,030
Operating Revenue
6,270 4,026 6,016 6,255 6,294 4,023 5,954 6,344 6,517 6,133 6,030
Total Cost of Revenue
3,716 2,926 3,485 3,571 3,647 2,900 3,478 3,646 3,792 4,075 3,574
Operating Cost of Revenue
3,716 2,926 3,485 3,571 3,647 2,900 3,478 3,646 3,792 4,075 3,574
Total Operating Expenses
5,650 576 1,382 1,412 1,331 390 1,230 1,558 1,278 1,262 1,059
Selling, General & Admin Expense
5,419 459 1,128 1,132 1,062 291 945 1,267 820 965 744
Research & Development Expense
267 117 254 280 269 99 285 288 297 299 308
Other Operating Expenses / (Income)
- - - - - - 0.00 - - - 7.00
Total Other Income / (Expense), net
-206 -252 -220 138 405 -282 139 -217 -300 -38 -519
Other Income / (Expense), net
- - - - - - 139 - - - -519
Income Tax Expense
-777 -39 220 203 348 -52 265 245 308 185 221
Net Income / (Loss) Attributable to Noncontrolling Interest
4.00 2.00 5.00 6.00 4.00 - 6.00 2.00 7.00 -3.00 6.00
Basic Earnings per Share
($3.74) $1.71 $1.67 $2.07 $2.49 $1.32 $2.05 $1.35 $1.56 $1.07 $1.23
Weighted Average Basic Shares Outstanding
554.30M 553.90M 555M 553.80M 550.60M 550.80M 543.80M 537.40M 534.10M 537.40M 529.10M
Diluted Earnings per Share
($3.74) $1.71 $1.67 $2.07 $2.48 $1.32 $2.04 $1.34 $1.55 $1.07 $1.23
Weighted Average Diluted Shares Outstanding
554.30M 553.90M 555.90M 554.80M 552.70M 552.40M 543.80M 540.60M 538.10M 541.30M 529.10M
Weighted Average Basic & Diluted Shares Outstanding
552.32M 552.70M 553.36M 549.35M 544.56M 542.90M 543.80M 532.63M 531.23M 526.70M 529.10M
Cash Dividends to Common per Share
$1.50 $1.49 $1.51 $0.70 - $0.70 $0.73 $0.73 - $0.72 $0.78

Annual Cash Flow Statements for 3M

This table details how cash moves in and out of 3M's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
-99 600 655 -200 -500 2,281 -70 -909 2,278 -333 -365
Net Cash From Operating Activities
6,420 6,662 6,240 6,439 7,070 8,113 7,454 5,591 6,680 1,819 2,306
Net Cash From Continuing Operating Activities
6,420 6,662 6,240 6,439 7,019 8,113 7,454 5,591 6,680 1,819 2,306
Net Income / (Loss) Continuing Operations
4,841 5,058 4,869 5,363 4,529 5,453 5,929 5,791 -6,979 4,188 3,262
Consolidated Net Income / (Loss)
4,841 5,058 4,869 5,363 4,529 5,453 5,929 5,791 -6,979 4,188 3,262
Depreciation Expense
1,435 1,474 1,544 1,488 1,593 1,911 1,915 1,831 1,987 1,363 1,308
Non-Cash Adjustments To Reconcile Net Income
364 54 -895 -203 494 45 300 -1,552 231 1,170 514
Changes in Operating Assets and Liabilities, net
-220 76 722 -209 403 704 -690 -479 11,441 -4,902 -2,778
Net Cash From Investing Activities
-2,817 -1,403 -3,086 222 -6,444 -580 -1,317 -1,046 -1,207 -3,206 1,350
Net Cash From Continuing Investing Activities
-2,817 -1,403 -3,086 222 -6,444 -580 -1,317 -1,046 -1,207 -3,206 1,350
Purchase of Property, Plant & Equipment
-1,461 -1,420 -1,373 -1,577 -1,699 -1,501 -1,603 -1,749 -1,615 -1,181 -910
Purchase of Investments
-652 -1,410 -2,152 -1,828 -1,635 -1,579 -2,202 -1,250 -1,466 -4,153 -1,305
Sale of Property, Plant & Equipment
33 58 49 262 123 128 51 200 119 61 95
Divestitures
123 142 1,065 859 236 576 0.00 13 60 0.00 5.00
Sale and/or Maturity of Investments
1,952 1,247 1,354 2,497 1,443 1,811 2,406 1,261 1,660 2,074 3,468
Other Investing Activities, net
102 -4.00 -6.00 9.00 72 10 31 1.00 35 -7.00 -3.00
Net Cash From Financing Activities
-3,648 -4,626 -2,655 -6,701 -1,124 -5,300 -6,145 -5,350 -3,147 1,098 -4,016
Net Cash From Continuing Financing Activities
-3,648 -4,626 -2,655 -6,701 -1,124 -5,300 -6,145 -5,350 -3,147 1,098 -4,016
Repayment of Debt
-60 -1,831 -1,083 -1,374 -3,229 -3,723 -1,166 -899 -2,902 -2,957 -1,864
Repurchase of Common Equity
-5,238 -3,753 -2,068 -4,870 -1,407 -368 -2,199 -1,464 -33 -1,801 -3,251
Payment of Dividends
-2,561 -2,678 -2,803 -3,193 -3,316 -3,388 -3,420 -3,369 -3,311 -2,603 -1,562
Issuance of Debt
3,422 2,832 2,565 2,251 6,281 1,750 1.00 1.00 2,835 8,367 1,099
Issuance of Common Equity
635 804 734 485 547 429 639 381 264 92 1,562
Other Net Changes in Cash
- - - - -2.00 - - - - -44 -46

Quarterly Cash Flow Statements for 3M

This table details how cash moves in and out of 3M's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents
882 793 4,978 -828 -4,033 -450 726 -2,614 959 564 -1,506
Net Cash From Operating Activities
1,910 1,986 767 1,021 -1,787 1,818 -79 -954 1,756 1,583 574
Net Cash From Continuing Operating Activities
1,910 1,986 767 1,021 -1,787 1,818 -79 -954 1,756 1,583 574
Net Income / (Loss) Continuing Operations
-2,071 947 933 1,151 1,376 728 1,122 725 841 574 659
Consolidated Net Income / (Loss)
-2,071 947 933 1,151 1,376 728 1,122 725 841 574 659
Depreciation Expense
535 537 430 301 310 322 290 290 298 430 326
Non-Cash Adjustments To Reconcile Net Income
20 17 35 977 67 91 131 75 239 69 86
Changes in Operating Assets and Liabilities, net
3,426 485 -631 -1,408 -3,540 677 -1,622 -2,044 378 510 -497
Net Cash From Investing Activities
-287 -301 -393 -463 -1,204 -1,146 1,220 70 465 -405 60
Net Cash From Continuing Investing Activities
-287 -301 -393 -463 -1,204 -1,146 1,220 70 465 -405 60
Purchase of Property, Plant & Equipment
-405 -358 -375 -269 -246 -291 -236 -208 -218 -248 -225
Purchase of Investments
-368 -323 -399 -544 -1,277 -1,933 -156 -263 -420 -466 -155
Sale of Property, Plant & Equipment
91 5.00 21 32 2.00 6.00 18 3.00 48 26 2.00
Sale and/or Maturity of Investments
347 368 388 319 315 1,052 1,597 533 1,055 283 436
Other Investing Activities, net
-12 7.00 -28 -1.00 2.00 20 -3.00 - - - 2.00
Net Cash From Financing Activities
-704 -924 4,621 -1,358 -1,085 -1,080 -422 -1,769 -1,208 -617 -2,124
Net Cash From Continuing Financing Activities
-704 -924 4,621 -1,358 -1,085 -1,080 -422 -1,769 -1,208 -617 -2,124
Repayment of Debt
-805 -937 -2,908 -7.00 -26 -16 -756 -509 -578 -21 -15
Repurchase of Common Equity
-2.00 -2.00 -21 -400 -675 -705 -1,274 -953 -472 -552 -1,999
Payment of Dividends
-828 -828 -835 -963 -422 -383 -396 -390 -389 -387 -412
Issuance of Debt
904 824 8,367 - - - 1,099 - - - 0.00
Issuance of Common Equity
27 19 18 12 38 24 905 83 231 343 302
Effect of Exchange Rate Changes
- - - - - -42 7.00 - - - -13

Annual Balance Sheets for 3M

This table presents 3M's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
32,883 32,906 37,987 36,500 44,659 47,344 47,072 46,455 50,580 39,868 37,733
Total Current Assets
10,986 11,726 14,277 13,709 12,971 14,982 15,403 14,688 16,379 15,884 16,387
Cash & Equivalents
1,798 2,398 3,053 2,853 2,353 4,634 4,564 3,655 5,735 5,600 5,235
Short-Term Investments
118 280 1,076 380 98 404 201 238 50 2,128 698
Accounts Receivable
4,154 4,392 4,911 5,020 4,791 4,705 4,660 4,532 3,601 3,194 3,533
Inventories, net
3,518 3,385 4,034 4,366 4,134 4,239 4,985 5,372 3,944 3,698 3,661
Prepaid Expenses
- 821 937 741 704 675 654 435 344 493 391
Other Current Assets
1,398 450 266 349 891 325 339 456 326 771 2,823
Other Current Nonoperating Assets
- - - - - - - - 2,379 0.00 46
Plant, Property, & Equipment, net
8,515 8,516 8,866 8,738 9,333 9,421 9,429 9,178 7,690 7,388 7,101
Total Noncurrent Assets
13,382 12,664 14,844 14,053 22,355 22,941 22,240 22,589 26,511 16,596 14,245
Goodwill
9,249 9,166 10,513 10,051 13,444 13,802 13,486 12,790 6,382 6,281 6,419
Intangible Assets
2,601 2,320 2,936 2,657 6,379 5,835 5,288 4,699 1,323 1,210 1,103
Other Noncurrent Operating Assets
1,218 1,178 1,395 1,345 2,532 3,304 3,466 5,100 7,463 9,105 6,723
Total Liabilities & Shareholders' Equity
32,883 32,906 37,987 36,500 44,659 47,344 47,072 46,455 50,580 39,868 37,733
Total Liabilities
21,415 22,563 26,365 26,652 34,533 34,413 31,955 31,685 45,712 35,974 32,986
Total Current Liabilities
7,118 6,219 7,687 7,244 9,222 7,948 9,035 9,523 15,297 11,256 9,595
Short-Term Debt
2,044 972 1,853 1,211 2,795 806 1,307 1,938 2,947 1,919 1,670
Accounts Payable
1,694 1,798 1,945 2,266 2,228 2,561 2,994 3,183 2,776 2,660 2,702
Current Employee Benefit Liabilities
644 678 870 749 702 747 1,020 692 695 712 718
Other Current Liabilities
2,404 2,472 2,709 2,775 3,303 3,534 3,454 3,451 6,852 5,965 4,450
Other Current Nonoperating Liabilities
- - - - - - - - 1,723 0.00 55
Total Noncurrent Liabilities
14,297 16,344 18,678 19,408 25,311 26,465 22,920 22,162 30,415 24,718 23,391
Long-Term Debt
8,753 10,678 12,096 13,411 17,518 17,989 16,056 14,001 13,088 11,125 10,932
Noncurrent Employee Benefit Liabilities
3,520 4,018 3,620 2,987 3,911 4,405 2,870 1,966 2,156 1,813 1,631
Other Noncurrent Operating Liabilities
2,024 1,648 2,962 3,010 3,882 4,071 3,994 6,195 14,485 11,780 10,828
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
11,468 10,343 11,622 9,848 10,126 12,931 15,117 14,770 4,868 3,894 4,747
Total Preferred & Common Equity
11,429 10,298 11,563 9,796 10,063 12,867 15,046 14,722 4,807 3,842 4,702
Total Common Equity
11,429 10,298 11,563 9,796 10,063 12,867 15,046 14,722 4,807 3,842 4,702
Common Stock
4,800 5,070 5,361 5,652 5,916 6,171 6,438 6,700 6,965 7,238 7,449
Retained Earnings
36,296 37,907 39,115 40,636 42,135 43,821 45,821 47,950 37,479 36,797 38,258
Treasury Stock
- - -25,887 -29,626 -29,849 -29,404 -30,463 -33,255 -32,859 -34,462 -35,936
Accumulated Other Comprehensive Income / (Loss)
-6,359 -7,245 -7,026 -6,866 -8,139 -7,721 -6,750 -6,673 -6,778 -5,731 -5,069
Noncontrolling Interest
39 45 59 52 63 64 71 48 61 52 45

Quarterly Balance Sheets for 3M

This table presents 3M's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets
48,880 49,621 50,580 55,243 43,377 40,875 39,868 39,951 37,989 37,611 35,436
Total Current Assets
15,754 16,198 16,379 21,613 19,515 16,299 15,884 15,657 13,427 16,089 14,393
Cash & Equivalents
4,258 5,140 5,735 10,911 10,083 6,050 5,600 6,326 3,712 4,671 3,729
Short-Term Investments
56 73 50 60 255 1,245 2,128 698 502 517 420
Accounts Receivable
4,947 4,852 3,601 4,750 3,575 3,528 3,194 3,501 3,760 3,777 3,754
Inventories, net
5,280 5,065 3,944 4,897 4,060 4,039 3,698 3,869 4,077 3,893 3,690
Prepaid Expenses
674 578 344 655 444 470 436 485 642 514 407
Other Current Assets
539 490 326 340 1,098 967 828 778 734 2,673 2,344
Other Current Nonoperating Assets
- - 2,379 - 0.00 0.00 0.00 - - 44 49
Plant, Property, & Equipment, net
9,211 9,004 7,690 9,072 7,472 7,529 7,388 7,356 7,393 7,247 6,960
Total Noncurrent Assets
23,915 24,419 26,511 24,558 16,390 17,047 16,596 16,938 17,169 14,275 14,083
Goodwill
12,869 12,721 6,382 12,809 6,318 6,395 6,281 6,337 6,433 6,416 6,384
Intangible Assets
4,470 4,324 1,323 4,105 1,266 1,242 1,210 1,185 1,162 1,127 1,078
Other Noncurrent Operating Assets
6,576 7,374 7,463 7,644 8,806 9,410 9,105 9,416 9,574 6,732 6,621
Total Liabilities & Shareholders' Equity
48,880 49,621 50,580 55,243 43,377 40,875 39,868 39,951 37,989 37,611 35,436
Total Liabilities
41,023 44,890 45,712 50,310 39,389 36,181 35,974 35,428 33,638 32,936 32,125
Total Current Liabilities
10,936 15,466 15,297 13,156 14,345 11,391 11,256 9,451 7,808 8,733 9,032
Short-Term Debt
3,033 3,137 2,947 820 1,302 1,870 1,919 1,169 669 749 1,650
Accounts Payable
3,231 3,104 2,776 3,372 2,813 2,689 2,660 2,756 2,840 2,735 2,786
Current Employee Benefit Liabilities
785 905 695 607 602 703 712 451 594 668 420
Other Current Liabilities
3,715 8,100 6,852 7,974 9,221 5,656 5,634 4,716 3,390 4,203 4,120
Other Current Nonoperating Liabilities
- - 1,723 - 0.00 0.00 0.00 - - 54 56
Total Noncurrent Liabilities
30,087 29,424 30,415 37,154 25,044 24,790 24,718 25,977 25,830 24,203 23,093
Long-Term Debt
12,954 12,876 13,088 20,593 11,781 11,319 11,125 12,307 12,477 11,854 10,906
Noncurrent Employee Benefit Liabilities
1,912 1,846 2,156 2,320 1,717 1,716 1,813 1,804 1,808 1,649 1,586
Other Noncurrent Operating Liabilities
15,221 14,702 14,485 14,241 11,546 11,755 11,780 11,866 11,545 10,700 10,601
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
7,857 4,731 4,868 4,933 3,988 4,694 3,894 4,523 4,351 4,675 3,311
Total Preferred & Common Equity
7,798 4,672 4,807 4,866 3,916 4,642 3,842 4,464 4,290 4,628 3,263
Total Common Equity
7,798 4,672 4,807 4,866 3,916 4,642 3,842 4,464 4,290 4,628 3,263
Common Stock
6,867 6,912 6,965 6,982 7,155 7,191 7,238 7,310 7,354 7,406 7,509
Retained Earnings
40,290 37,375 37,479 37,472 35,475 36,459 36,797 37,432 37,693 38,103 38,162
Treasury Stock
-32,926 -32,889 -32,859 -32,762 -33,147 -33,784 -34,462 -34,747 -35,542 -35,759 -37,309
Accumulated Other Comprehensive Income / (Loss)
-6,433 -6,726 -6,778 -6,826 -5,567 -5,224 -5,731 -5,531 -5,215 -5,122 -5,099
Noncontrolling Interest
59 59 61 67 72 52 52 59 61 47 48

Annual Metrics And Ratios for 3M

This table displays calculated financial ratios and metrics derived from 3M's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-4.86% -0.55% 5.14% 3.50% -1.92% 0.15% 9.85% -26.00% -5.93% -0.14% 1.52%
EBITDA Growth
-3.34% 3.26% 6.63% -6.64% -14.75% 20.32% 6.64% -33.22% -240.35% 171.08% -4.01%
EBIT Growth
-4.37% 3.37% 7.02% -7.26% -19.39% 20.41% 8.45% -40.71% -344.66% 145.11% -4.00%
NOPAT Growth
-2.90% 2.25% -1.54% 11.28% -10.26% 16.08% 5.26% -31.07% -279.28% 153.69% -12.21%
Net Income Growth
-3.14% 4.48% -3.74% 10.15% -15.55% 20.40% 8.73% -2.33% -220.51% 160.01% -22.11%
EPS Growth
1.20% 7.65% -2.82% 12.11% -13.16% 21.24% 8.12% -2.33% -220.51% 159.78% -20.53%
Operating Cash Flow Growth
-3.11% 3.77% -6.33% 3.19% 9.80% 14.75% -8.12% -24.99% 19.48% -72.77% 26.77%
Free Cash Flow Firm Growth
-84.18% 393.45% -52.33% 102.00% -131.36% 492.69% -28.71% 0.90% 206.13% -108.94% 194.56%
Invested Capital Growth
22.56% -4.49% 11.01% -0.96% 31.79% -4.64% 3.85% -3.24% -85.81% 142.05% 24.05%
Revenue Q/Q Growth
-1.37% 0.10% 2.13% -0.14% 0.52% 1.49% 0.08% -24.74% -14.14% -24.73% 0.50%
EBITDA Q/Q Growth
-2.80% -0.21% 1.58% 0.83% -6.28% 7.71% 0.08% -34.05% -0.36% -20.21% -2.96%
EBIT Q/Q Growth
-4.01% -0.07% 2.39% 0.69% -9.28% 9.47% -0.03% -41.92% -1.02% -21.90% -5.88%
NOPAT Q/Q Growth
-2.59% -0.21% -8.39% 17.25% -6.32% 8.34% -2.03% -37.97% -1.02% -22.57% -10.14%
Net Income Q/Q Growth
-2.81% 2.37% -11.47% 18.15% -8.71% 9.85% -1.10% -12.10% 5.47% -4.97% -4.51%
EPS Q/Q Growth
-1.94% 2.77% -11.40% 18.69% -8.20% 9.86% -2.03% -12.10% 5.47% -5.27% -5.81%
Operating Cash Flow Q/Q Growth
2.56% -2.83% -5.30% 6.59% 1.14% 2.23% -6.40% -1.46% 0.97% -8.46% -9.25%
Free Cash Flow Firm Q/Q Growth
-61.20% 17.96% -57.85% 70.06% -140.07% 814.70% -18.88% -31.62% 365.73% -113.69% -45.63%
Invested Capital Q/Q Growth
-6.35% -10.59% 5.67% -1.84% 24.71% -1.08% 2.79% 2.07% -75.50% -13.01% -5.58%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
49.19% 49.79% 49.28% 49.09% 46.68% 48.41% 46.84% 39.40% 39.12% 41.21% 39.91%
EBITDA Margin
27.28% 28.32% 28.72% 25.91% 22.52% 27.05% 26.26% 23.70% -35.36% 25.17% 23.80%
Operating Margin
22.94% 23.34% 24.30% 22.00% 19.21% 22.25% 20.84% 16.70% -43.43% 19.62% 18.55%
EBIT Margin
22.54% 23.42% 23.84% 21.36% 17.56% 21.11% 20.84% 16.70% -43.43% 19.62% 18.55%
Profit (Net Income) Margin
15.99% 16.80% 15.38% 16.37% 14.09% 16.94% 16.77% 22.14% -28.36% 17.04% 13.08%
Tax Burden Percent
70.95% 71.71% 64.51% 76.61% 80.26% 80.25% 82.30% 137.75% 61.92% 86.91% 77.43%
Interest Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 97.76% 96.22% 105.44% 99.94% 91.01%
Effective Tax Rate
29.05% 28.29% 35.49% 23.39% 19.74% 19.68% 17.84% 4.47% 0.00% 16.68% 23.81%
Return on Invested Capital (ROIC)
26.84% 25.49% 24.35% 25.88% 20.13% 21.04% 22.26% 15.31% -48.87% 61.74% 34.18%
ROIC Less NNEP Spread (ROIC-NNEP)
25.40% 25.70% 23.36% 24.38% 17.22% 19.15% 21.31% 28.43% -39.71% 69.75% 29.77%
Return on Net Nonoperating Assets (RNNOA)
12.50% 20.89% 19.99% 24.08% 25.22% 26.26% 20.02% 23.45% -22.21% 33.86% 41.32%
Return on Equity (ROE)
39.34% 46.38% 44.33% 49.96% 45.35% 47.30% 42.28% 38.75% -71.08% 95.59% 75.50%
Cash Return on Invested Capital (CROIC)
6.56% 30.08% 13.91% 26.84% -7.30% 25.80% 18.48% 18.60% 101.43% -21.32% 12.72%
Operating Return on Assets (OROA)
21.29% 21.44% 21.29% 18.80% 13.91% 14.77% 15.61% 9.34% -22.03% 10.66% 11.93%
Return on Assets (ROA)
15.11% 15.38% 13.74% 14.40% 11.16% 11.85% 12.56% 12.38% -14.38% 9.26% 8.41%
Return on Common Equity (ROCE)
39.23% 46.20% 44.12% 49.70% 45.09% 47.04% 42.07% 38.60% -70.68% 94.36% 74.65%
Return on Equity Simple (ROE_SIMPLE)
42.36% 49.12% 42.11% 54.75% 45.01% 42.38% 39.41% 39.34% -145.18% 109.01% 0.00%
Net Operating Profit after Tax (NOPAT)
4,928 5,039 4,962 5,522 4,955 5,752 6,055 4,174 -7,482 4,017 3,527
NOPAT Margin
16.28% 16.74% 15.67% 16.85% 15.42% 17.87% 17.13% 15.95% -30.40% 16.35% 14.14%
Net Nonoperating Expense Percent (NNEP)
1.44% -0.21% 0.99% 1.50% 2.91% 1.89% 0.95% -13.13% -9.17% -8.02% 4.42%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - 13.59% -35.80% 23.72% 20.33%
Cost of Revenue to Revenue
50.81% 50.21% 50.72% 50.91% 53.32% 51.59% 53.16% 60.60% 60.88% 58.79% 60.09%
SG&A Expenses to Revenue
20.58% 20.96% 20.93% 23.20% 21.87% 21.53% 20.36% 27.64% 78.01% 17.18% 16.02%
R&D to Revenue
5.82% 5.86% 5.91% 5.56% 5.95% 5.84% 5.64% 4.43% 4.69% 4.42% 4.69%
Operating Expenses to Revenue
26.40% 26.45% 24.99% 27.09% 27.46% 26.16% 26.00% 22.70% 82.55% 21.59% 21.36%
Earnings before Interest and Taxes (EBIT)
6,823 7,053 7,548 7,000 5,643 6,795 7,369 4,369 -10,689 4,822 4,629
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
8,258 8,527 9,092 8,488 7,236 8,706 9,284 6,200 -8,702 6,185 5,937
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
5.98 7.89 9.38 9.00 8.28 6.68 5.98 4.10 12.14 18.30 18.09
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
2.26 2.70 3.43 2.69 2.59 2.67 2.54 2.31 2.37 2.86 3.41
Price to Earnings (P/E)
14.14 16.08 22.34 16.48 18.45 15.76 15.20 10.46 0.00 16.85 26.17
Dividend Yield
3.70% 3.29% 2.58% 3.59% 3.98% 3.95% 3.79% 5.45% 5.68% 2.61% 1.82%
Earnings Yield
7.07% 6.22% 4.48% 6.07% 5.42% 6.34% 6.58% 9.56% 0.00% 5.94% 3.82%
Enterprise Value to Invested Capital (EV/IC)
3.81 4.67 5.52 4.69 3.62 3.74 3.70 2.70 18.05 8.22 8.03
Enterprise Value to Revenue (EV/Rev)
2.55 3.00 3.74 3.04 3.15 3.10 2.90 2.77 2.79 3.08 3.68
Enterprise Value to EBITDA (EV/EBITDA)
9.34 10.58 13.02 11.73 13.99 11.45 11.06 11.69 0.00 12.23 15.46
Enterprise Value to EBIT (EV/EBIT)
11.30 12.80 15.69 14.23 17.94 14.67 13.93 16.60 0.00 15.69 19.82
Enterprise Value to NOPAT (EV/NOPAT)
15.65 17.91 23.86 18.04 20.43 17.34 16.95 17.37 0.00 18.83 26.02
Enterprise Value to Operating Cash Flow (EV/OCF)
12.01 13.55 18.97 15.47 14.32 12.29 13.77 12.97 10.28 41.60 39.79
Enterprise Value to Free Cash Flow (EV/FCFF)
63.98 15.17 41.76 17.39 0.00 14.14 20.42 14.29 4.42 0.00 69.94
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.94 1.13 1.20 1.48 2.01 1.45 1.15 1.08 3.29 3.35 2.65
Long-Term Debt to Equity
0.76 1.03 1.04 1.36 1.73 1.39 1.06 0.95 2.69 2.86 2.30
Financial Leverage
0.49 0.81 0.86 0.99 1.46 1.37 0.94 0.82 0.56 0.49 1.39
Leverage Ratio
2.60 3.02 3.23 3.47 4.06 3.99 3.37 3.13 4.94 10.32 8.98
Compound Leverage Factor
2.60 3.02 3.23 3.47 4.06 3.99 3.29 3.01 5.21 10.32 8.17
Debt to Total Capital
48.49% 52.97% 54.55% 59.75% 66.73% 59.24% 53.46% 51.90% 76.71% 77.01% 72.64%
Short-Term Debt to Total Capital
9.18% 4.42% 7.25% 4.95% 9.18% 2.54% 4.02% 6.31% 14.10% 11.33% 9.63%
Long-Term Debt to Total Capital
39.31% 48.55% 47.30% 54.81% 57.55% 56.70% 49.43% 45.59% 62.61% 65.68% 63.01%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.18% 0.20% 0.23% 0.21% 0.21% 0.20% 0.22% 0.16% 0.29% 0.31% 0.26%
Common Equity to Total Capital
51.33% 46.82% 45.22% 40.03% 33.06% 40.56% 46.32% 47.94% 23.00% 22.68% 27.10%
Debt to EBITDA
1.31 1.37 1.53 1.72 2.81 2.16 1.87 2.57 -1.84 2.11 2.12
Net Debt to EBITDA
1.06 1.05 1.08 1.34 2.47 1.58 1.36 1.94 -1.18 0.86 1.12
Long-Term Debt to EBITDA
1.06 1.25 1.33 1.58 2.42 2.07 1.73 2.26 -1.50 1.80 1.84
Debt to NOPAT
2.19 2.31 2.81 2.65 4.10 3.27 2.87 3.82 -2.14 3.25 3.57
Net Debt to NOPAT
1.78 1.78 1.98 2.06 3.60 2.39 2.08 2.89 -1.37 1.32 1.89
Long-Term Debt to NOPAT
1.78 2.12 2.44 2.43 3.54 3.13 2.65 3.35 -1.75 2.77 3.10
Altman Z-Score
5.21 5.60 5.61 5.29 4.01 4.13 4.48 3.60 1.62 3.62 4.25
Noncontrolling Interest Sharing Ratio
0.29% 0.39% 0.47% 0.52% 0.58% 0.55% 0.48% 0.40% 0.56% 1.29% 1.12%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.54 1.89 1.86 1.89 1.41 1.89 1.70 1.54 1.07 1.41 1.71
Quick Ratio
0.85 1.14 1.18 1.14 0.79 1.23 1.04 0.88 0.61 0.97 0.99
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
1,205 5,947 2,835 5,727 -1,796 7,052 5,028 5,073 15,529 -1,388 1,312
Operating Cash Flow to CapEx
449.58% 489.13% 471.30% 489.66% 448.60% 590.90% 480.28% 360.94% 446.52% 162.41% 282.94%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.94 0.92 0.89 0.88 0.79 0.70 0.75 0.56 0.51 0.54 0.64
Accounts Receivable Turnover
7.22 7.05 6.81 6.60 6.55 6.78 7.55 5.69 6.05 7.23 7.42
Inventory Turnover
4.26 4.38 4.33 3.97 4.03 3.97 4.08 3.06 3.22 3.78 4.07
Fixed Asset Turnover
3.56 3.54 3.64 3.72 3.56 3.43 3.75 2.81 2.92 3.26 3.44
Accounts Payable Turnover
8.79 8.66 8.58 7.92 7.63 6.93 6.77 5.13 5.03 5.32 5.59
Days Sales Outstanding (DSO)
50.59 51.80 53.63 55.32 55.72 53.85 48.34 64.12 60.31 50.46 49.21
Days Inventory Outstanding (DIO)
85.70 83.33 84.33 91.90 90.53 92.02 89.57 119.23 113.47 96.54 89.59
Days Payable Outstanding (DPO)
41.54 42.15 42.55 46.07 47.86 52.63 53.94 71.11 72.58 68.67 65.28
Cash Conversion Cycle (CCC)
94.76 92.98 95.42 101.14 98.38 93.24 83.97 112.24 101.20 78.33 73.52
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
20,223 19,315 21,442 21,237 27,988 26,688 27,715 26,816 3,805 9,210 11,425
Invested Capital Turnover
1.65 1.52 1.55 1.54 1.31 1.18 1.30 0.96 1.61 3.78 2.42
Increase / (Decrease) in Invested Capital
3,723 -908 2,127 -205 6,751 -1,300 1,027 -899 -23,011 5,405 2,215
Enterprise Value (EV)
77,110 90,245 118,391 99,599 101,252 99,716 102,641 72,506 68,668 75,665 91,763
Market Capitalization
68,316 81,228 108,512 88,158 83,327 85,895 89,972 60,412 58,357 70,297 85,049
Book Value per Share
$18.56 $17.12 $19.41 $16.82 $17.50 $22.31 $26.11 $26.63 $8.70 $7.06 $8.85
Tangible Book Value per Share
($0.68) ($1.98) ($3.17) ($5.00) ($16.97) ($11.74) ($6.47) ($5.01) ($5.25) ($6.70) ($5.31)
Total Capital
22,265 21,993 25,571 24,470 30,439 31,726 32,480 30,709 20,903 16,938 17,349
Total Debt
10,797 11,650 13,949 14,622 20,313 18,795 17,363 15,939 16,035 13,044 12,602
Total Long-Term Debt
8,753 10,678 12,096 13,411 17,518 17,989 16,056 14,001 13,088 11,125 10,932
Net Debt
8,755 8,972 9,820 11,389 17,862 13,757 12,598 12,046 10,250 5,316 6,669
Capital Expenditures (CapEx)
1,428 1,362 1,324 1,315 1,576 1,373 1,552 1,549 1,496 1,120 815
Debt-free, Cash-free Net Working Capital (DFCFNWC)
3,996 3,801 4,314 4,443 4,093 2,802 2,910 3,210 -1,756 -1,181 2,529
Debt-free Net Working Capital (DFNWC)
5,912 6,479 8,443 7,676 6,544 7,840 7,675 7,103 4,029 6,547 8,462
Net Working Capital (NWC)
3,868 5,507 6,590 6,465 3,749 7,034 6,368 5,165 1,082 4,628 6,792
Net Nonoperating Expense (NNE)
87 -19 93 159 426 299 126 -1,617 -503 -171 265
Net Nonoperating Obligations (NNO)
8,755 8,972 9,820 11,389 17,862 13,757 12,598 12,046 -1,063 5,316 6,678
Total Depreciation and Amortization (D&A)
1,435 1,474 1,544 1,488 1,593 1,911 1,915 1,831 1,987 1,363 1,308
Debt-free, Cash-free Net Working Capital to Revenue
13.20% 12.62% 13.63% 13.56% 12.74% 8.71% 8.23% 12.27% -7.14% -4.81% 10.14%
Debt-free Net Working Capital to Revenue
19.53% 21.52% 26.67% 23.43% 20.36% 24.36% 21.71% 27.15% 16.37% 26.64% 33.92%
Net Working Capital to Revenue
12.78% 18.29% 20.82% 19.73% 11.67% 21.86% 18.01% 19.74% 4.40% 18.83% 27.22%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$6.46 $6.99 $6.80 $7.61 $6.63 $7.80 $8.56 $8.55 ($10.57) $7.58 $6.05
Adjusted Weighted Average Basic Shares Outstanding
747.42M 722.45M 713.84M 703.09M 689.35M 690.07M 691.74M 676.21M 661.75M 550.80M 537.40M
Adjusted Diluted Earnings per Share
$6.34 $6.83 $6.64 $7.44 $6.54 $7.74 $8.47 $8.52 ($10.57) $7.55 $6.00
Adjusted Weighted Average Diluted Shares Outstanding
761.27M 739.17M 732.00M 719.22M 699.03M 695.56M 699.27M 678.12M 661.75M 552.40M 541.30M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
722.85M 712.29M 711.45M 687.92M 687.68M 691.86M 682.30M 657.69M 660.32M 542.90M 526.70M
Normalized Net Operating Profit after Tax (NOPAT)
4,895 5,039 4,962 5,522 4,955 5,752 6,055 1,830 -7,508 4,017 3,650
Normalized NOPAT Margin
16.17% 16.74% 15.67% 16.85% 15.42% 17.87% 17.13% 7.00% -30.51% 16.35% 14.63%
Pre Tax Income Margin
22.54% 23.42% 23.84% 21.36% 17.56% 21.11% 20.38% 16.07% -45.80% 19.61% 16.89%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
52.90% 52.95% 57.57% 59.54% 73.22% 62.13% 57.68% 58.18% -47.44% 62.15% 47.88%
Augmented Payout Ratio
161.10% 127.15% 100.04% 150.35% 104.28% 68.88% 94.77% 83.46% -47.92% 105.16% 147.55%

Quarterly Metrics And Ratios for 3M

This table displays calculated financial ratios and metrics derived from 3M's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding
- - - - - - - - - - 521,567,261.00
DEI Adjusted Shares Outstanding
- - - - - - - - - - 521,567,261.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - - 1.25
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-27.25% 36,500.00% -0.35% -0.45% 0.38% -0.07% -1.03% 1.42% 3.54% 2.05% 1.28%
EBITDA Growth
-155.60% 198.42% 13.12% 119.05% 163.49% -0.57% -2.72% -9.09% 7.32% -12.86% -28.12%
EBIT Growth
-174.49% 134.07% 20.95% 114.95% 142.51% 39.89% 8.44% -10.38% 9.95% -26.64% -36.61%
NOPAT Growth
-155.81% 155.65% 10.68% 116.62% 148.44% 36.45% 14.90% -23.09% 0.81% -42.02% 3.75%
Net Income Growth
-153.61% 74.40% -4.89% 116.84% 166.44% -23.13% 20.26% -37.01% -38.88% -21.15% -41.27%
EPS Growth
-153.61% 74.40% -4.89% 116.76% 166.31% -22.81% 22.16% -35.27% -37.50% -18.94% -39.71%
Operating Cash Flow Growth
24.76% 3.33% -39.84% -32.34% -193.56% -8.46% -110.30% -193.44% 198.27% -12.93% 826.58%
Free Cash Flow Firm Growth
87.47% 13,393.99% 553.97% 1,251.55% -30.10% -119.43% -57.90% -141.14% -107.57% 63.06% -94.54%
Invested Capital Growth
-40.88% -85.81% -43.77% -65.52% -31.83% 142.05% -28.62% 97.28% 14.28% 24.05% 6.83%
Revenue Q/Q Growth
-0.21% -35.79% -20.41% -21.84% 0.62% -36.08% 48.00% 6.55% 2.73% -5.89% -1.68%
EBITDA Q/Q Growth
71.48% 141.43% -11.42% -11.39% -4.97% -35.12% 45.59% -6.90% 22.03% -29.74% -1.79%
EBIT Q/Q Growth
67.17% 116.93% -8.64% -6.06% -6.67% -44.30% 69.99% -8.51% 26.93% -44.99% 10.30%
NOPAT Q/Q Growth
66.92% 127.65% -23.50% -3.72% -3.58% -22.13% 23.25% -16.89% 26.40% -43.15% 73.73%
Net Income Q/Q Growth
69.70% 145.73% -1.48% 23.37% 19.55% -47.09% 54.12% -35.38% 16.00% -31.75% 14.81%
EPS Q/Q Growth
69.70% 145.73% -1.48% 23.95% 19.81% -46.77% 54.55% -34.31% 15.67% -30.97% 14.95%
Operating Cash Flow Q/Q Growth
26.57% 3.98% -61.38% 33.12% -275.02% 201.73% -104.35% -1,107.59% 284.07% -9.85% -63.74%
Free Cash Flow Firm Q/Q Growth
734.51% 175.38% -46.52% 6.02% -56.84% -176.55% 217.88% -205.64% 92.06% -255.69% 118.31%
Invested Capital Q/Q Growth
-20.48% -75.50% 304.07% -56.21% 57.26% -13.01% 19.16% 21.03% -8.91% -5.58% 2.63%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
40.73% 27.32% 45.91% 42.91% 42.06% 27.91% 41.59% 42.53% 41.81% 33.56% 40.73%
EBITDA Margin
-40.85% 26.35% 24.13% 27.35% 25.83% 26.22% 25.80% 22.54% 26.78% 19.99% 19.97%
Operating Margin
-49.38% 13.02% 18.76% 20.34% 20.91% 18.22% 20.93% 17.97% 22.20% 12.98% 23.17%
EBIT Margin
-49.38% 13.02% 18.76% 22.54% 20.91% 18.22% 20.93% 17.97% 22.20% 12.98% 14.56%
Profit (Net Income) Margin
-33.03% 23.52% 11.66% 18.40% 21.86% 18.10% 18.84% 11.43% 12.90% 9.36% 10.93%
Tax Burden Percent
62.72% 348.16% 75.42% 81.63% 79.95% 161.42% 81.01% 78.55% 73.32% 75.73% 75.06%
Interest Burden Percent
106.65% 51.91% 82.41% 100.00% 130.78% 61.53% 111.16% 80.96% 79.27% 95.23% 100.00%
Effective Tax Rate
0.00% -14.34% 24.66% 14.40% 20.22% -11.53% 19.13% 26.54% 26.85% 24.41% 25.17%
Return on Invested Capital (ROIC)
-47.40% 23.92% 21.60% 43.25% 41.70% 76.74% 31.49% 32.45% 35.54% 23.72% 38.22%
ROIC Less NNEP Spread (ROIC-NNEP)
-46.56% 30.26% 19.84% 44.11% 45.61% 72.53% 32.84% 30.52% 32.28% 23.26% 33.02%
Return on Net Nonoperating Assets (RNNOA)
-56.49% 16.92% 21.94% 53.69% 80.79% 35.21% 58.67% 42.74% 45.88% 32.29% 62.67%
Return on Equity (ROE)
-103.89% 40.84% 43.54% 96.94% 122.49% 111.95% 90.16% 75.19% 81.43% 56.01% 100.89%
Cash Return on Invested Capital (CROIC)
15.95% 101.43% 26.97% 112.35% 77.58% -21.32% 64.72% -26.52% 21.27% 12.72% 24.61%
Operating Return on Assets (OROA)
-29.55% 6.60% 11.99% 15.94% 15.09% 9.90% 10.78% 10.87% 14.05% 8.35% 9.67%
Return on Assets (ROA)
-19.77% 11.93% 7.45% 13.01% 15.77% 9.83% 9.71% 6.91% 8.16% 6.02% 7.26%
Return on Common Equity (ROCE)
-103.15% 40.61% 43.29% 95.87% 121.05% 110.50% 88.96% 73.99% 80.57% 55.38% 99.51%
Return on Equity Simple (ROE_SIMPLE)
-158.03% 0.00% -144.41% 24.51% 94.94% 0.00% 98.05% 92.10% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
-2,167 599 1,131 1,089 1,050 818 1,008 837 1,058 602 1,045
NOPAT Margin
-34.56% 14.88% 14.13% 17.41% 16.68% 20.32% 16.92% 13.20% 16.24% 9.81% 17.34%
Net Nonoperating Expense Percent (NNEP)
-0.84% -6.33% 1.76% -0.86% -3.91% 4.21% -1.35% 1.93% 3.27% 0.46% 5.20%
Return On Investment Capital (ROIC_SIMPLE)
- 2.87% - - - 4.83% 5.60% 4.79% 6.13% 3.47% 6.59%
Cost of Revenue to Revenue
59.27% 72.68% 54.09% 57.09% 57.94% 72.09% 58.41% 57.47% 58.19% 66.44% 59.27%
SG&A Expenses to Revenue
86.43% 11.40% 21.69% 18.10% 16.87% 7.23% 15.87% 19.97% 12.58% 15.73% 12.34%
R&D to Revenue
4.26% 2.91% 5.46% 4.48% 4.27% 2.46% 4.79% 4.54% 4.56% 4.88% 5.11%
Operating Expenses to Revenue
90.11% 14.31% 27.15% 22.57% 21.15% 9.69% 20.66% 24.56% 19.61% 20.58% 17.56%
Earnings before Interest and Taxes (EBIT)
-3,096 524 1,501 1,410 1,316 733 1,246 1,140 1,447 796 878
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-2,561 1,061 1,931 1,711 1,626 1,055 1,536 1,430 1,745 1,226 1,204
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
10.58 12.14 11.89 14.36 16.18 18.30 17.86 19.10 17.86 18.09 23.44
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
1.72 2.37 1.77 1.72 2.30 2.86 3.25 3.33 3.33 3.41 3.06
Price to Earnings (P/E)
0.00 0.00 0.00 59.64 17.11 16.85 18.28 20.80 24.30 26.17 27.45
Dividend Yield
6.69% 5.68% 5.74% 4.40% 2.87% 2.61% 1.93% 1.88% 1.86% 1.82% 2.05%
Earnings Yield
0.00% 0.00% 0.00% 1.68% 5.85% 5.94% 5.47% 4.81% 4.11% 3.82% 3.64%
Enterprise Value to Invested Capital (EV/IC)
3.88 18.05 4.45 8.77 7.65 8.22 7.86 6.85 7.45 8.03 7.25
Enterprise Value to Revenue (EV/Rev)
2.10 2.79 2.09 1.81 2.48 3.08 3.52 3.70 3.63 3.68 3.39
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 16.57 10.45 12.23 14.04 15.16 14.73 15.46 13.87
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 33.52 13.13 15.69 17.53 18.99 18.32 19.82 17.77
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 30.20 15.62 18.83 20.90 23.34 22.96 26.02 23.98
Enterprise Value to Operating Cash Flow (EV/OCF)
9.11 10.28 11.08 10.39 40.79 41.60 88.63 0.00 35.46 39.79 28.71
Enterprise Value to Free Cash Flow (EV/FCFF)
18.08 4.42 11.87 4.00 8.00 0.00 10.11 0.00 37.35 69.94 30.41
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
3.38 3.29 4.34 3.28 2.81 3.35 2.98 3.02 2.70 2.65 3.79
Long-Term Debt to Equity
2.72 2.69 4.17 2.95 2.41 2.86 2.72 2.87 2.54 2.30 3.29
Financial Leverage
1.21 0.56 1.11 1.22 1.77 0.49 1.79 1.40 1.42 1.39 1.90
Leverage Ratio
5.07 4.94 5.04 7.79 9.60 10.32 10.07 9.76 8.38 8.98 9.62
Compound Leverage Factor
5.41 2.56 4.15 7.79 12.56 6.35 11.19 7.90 6.64 8.55 9.62
Debt to Total Capital
77.19% 76.71% 81.28% 76.64% 73.75% 77.01% 74.87% 75.13% 72.94% 72.64% 79.13%
Short-Term Debt to Total Capital
15.12% 14.10% 3.11% 7.63% 10.46% 11.33% 6.49% 3.82% 4.34% 9.63% 10.40%
Long-Term Debt to Total Capital
62.07% 62.61% 78.16% 69.01% 63.29% 65.68% 68.38% 71.31% 68.61% 63.01% 68.73%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.28% 0.29% 0.25% 0.42% 0.29% 0.31% 0.33% 0.35% 0.27% 0.26% 0.30%
Common Equity to Total Capital
22.52% 23.00% 18.47% 22.94% 25.96% 22.68% 24.80% 24.52% 26.79% 27.10% 20.56%
Debt to EBITDA
-1.85 -1.84 -3.10 3.67 1.70 2.11 2.19 2.19 2.06 2.12 2.05
Net Debt to EBITDA
-1.25 -1.18 -1.51 0.77 0.76 0.86 1.05 1.49 1.21 1.12 1.37
Long-Term Debt to EBITDA
-1.48 -1.50 -2.98 3.30 1.46 1.80 2.00 2.08 1.94 1.84 1.78
Debt to NOPAT
-2.16 -2.14 -3.45 6.69 2.54 3.25 3.27 3.37 3.21 3.57 3.54
Net Debt to NOPAT
-1.46 -1.37 -1.68 1.40 1.14 1.32 1.56 2.29 1.89 1.89 2.37
Long-Term Debt to NOPAT
-1.74 -1.75 -3.32 6.02 2.18 2.77 2.98 3.20 3.02 3.10 3.08
Altman Z-Score
2.10 2.35 2.50 3.00 3.54 3.28 3.56 3.77 3.95 3.91 3.91
Noncontrolling Interest Sharing Ratio
0.71% 0.56% 0.59% 1.11% 1.18% 1.29% 1.33% 1.59% 1.06% 1.12% 1.37%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.05 1.07 1.64 1.36 1.43 1.41 1.66 1.72 1.84 1.71 1.59
Quick Ratio
0.65 0.61 1.20 0.97 0.95 0.97 1.11 1.02 1.03 0.99 0.88
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
8,574 23,610 13,098 13,886 5,993 -4,587 5,408 -5,713 -454 -1,613 295
Operating Cash Flow to CapEx
608.28% 562.61% 216.67% 430.80% -732.38% 637.89% -36.24% -465.37% 1,032.94% 713.06% 257.40%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.60 0.51 0.64 0.71 0.72 0.54 0.52 0.60 0.63 0.64 0.66
Accounts Receivable Turnover
5.99 6.05 6.96 7.66 7.79 7.23 5.94 6.71 6.80 7.42 6.90
Inventory Turnover
3.12 3.22 3.57 3.86 3.95 3.78 3.29 3.57 3.70 4.07 3.99
Fixed Asset Turnover
3.15 2.92 3.56 3.91 3.95 3.26 2.98 3.31 3.36 3.44 3.50
Accounts Payable Turnover
5.40 5.03 5.60 5.97 6.20 5.32 4.71 5.14 5.41 5.59 5.44
Days Sales Outstanding (DSO)
60.96 60.31 52.47 47.67 46.84 50.46 61.43 54.41 53.70 49.21 52.91
Days Inventory Outstanding (DIO)
117.12 113.47 102.35 94.51 92.47 96.54 110.79 102.31 98.74 89.59 91.44
Days Payable Outstanding (DPO)
67.63 72.58 65.22 61.16 58.84 68.67 77.45 71.08 67.52 65.28 67.04
Cash Conversion Cycle (CCC)
110.45 101.20 89.60 81.02 80.47 78.33 94.77 85.64 84.92 73.52 77.31
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
15,531 3,805 15,375 6,733 10,588 9,210 10,975 13,283 12,100 11,425 11,725
Invested Capital Turnover
1.37 1.61 1.53 2.48 2.50 3.78 1.86 2.46 2.19 2.42 2.20
Increase / (Decrease) in Invested Capital
-10,741 -23,011 -11,967 -12,797 -4,943 5,405 -4,400 6,550 1,512 2,215 750
Enterprise Value (EV)
60,293 68,668 68,377 59,062 81,043 75,665 86,241 90,926 90,115 91,763 84,948
Market Capitalization
49,434 58,357 57,868 56,245 75,097 70,297 79,730 81,933 82,653 85,049 76,493
Book Value per Share
$8.46 $8.70 $8.77 $7.08 $8.45 $7.06 $8.22 $7.97 $8.69 $8.85 $6.20
Tangible Book Value per Share
($22.42) ($5.25) ($21.71) ($6.63) ($5.45) ($6.70) ($5.63) ($6.14) ($5.47) ($5.31) ($7.97)
Total Capital
20,744 20,903 26,346 17,071 17,883 16,938 17,999 17,497 17,278 17,349 15,867
Total Debt
16,013 16,035 21,413 13,083 13,189 13,044 13,476 13,146 12,603 12,602 12,556
Total Long-Term Debt
12,876 13,088 20,593 11,781 11,319 11,125 12,307 12,477 11,854 10,932 10,906
Net Debt
10,800 10,250 10,442 2,745 5,894 5,316 6,452 8,932 7,415 6,669 8,407
Capital Expenditures (CapEx)
314 353 354 237 244 285 218 205 170 222 223
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-1,344 -1,756 -1,694 -3,866 -517 -1,181 351 2,074 2,917 2,529 2,862
Debt-free Net Working Capital (DFNWC)
3,869 4,029 9,277 6,472 6,778 6,547 7,375 6,288 8,105 8,462 7,011
Net Working Capital (NWC)
732 1,082 8,457 5,170 4,908 4,628 6,206 5,619 7,356 6,792 5,361
Net Nonoperating Expense (NNE)
-96 -348 198 -62 -326 90 -114 112 217 28 386
Net Nonoperating Obligations (NNO)
10,800 -1,063 10,442 2,745 5,894 5,316 6,452 8,932 7,425 6,678 8,414
Total Depreciation and Amortization (D&A)
535 537 430 301 310 322 290 290 298 430 326
Debt-free, Cash-free Net Working Capital to Revenue
-4.69% -7.14% -5.19% -11.85% -1.58% -4.81% 1.43% 8.43% 11.75% 10.14% 11.44%
Debt-free Net Working Capital to Revenue
13.50% 16.37% 28.41% 19.84% 20.76% 26.64% 30.09% 25.56% 32.65% 33.92% 28.02%
Net Working Capital to Revenue
2.55% 4.40% 25.90% 15.85% 15.03% 18.83% 25.32% 22.84% 29.63% 27.22% 21.42%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($3.13) $1.43 $1.67 $2.07 $2.49 $1.32 $2.05 $1.35 $1.56 $1.07 $1.23
Adjusted Weighted Average Basic Shares Outstanding
662.23M 661.75M 555M 553.80M 550.60M 550.80M 543.80M 537.40M 534.10M 537.40M 529.10M
Adjusted Diluted Earnings per Share
($3.13) $1.43 $1.67 $2.07 $2.48 $1.32 $2.04 $1.34 $1.55 $1.07 $1.23
Adjusted Weighted Average Diluted Shares Outstanding
662.23M 661.75M 555.90M 554.80M 552.70M 552.40M 547.70M 540.60M 538.10M 541.30M 529.10M
Adjusted Basic & Diluted Earnings per Share
$0.00 $1.43 $0.00 $0.00 $0.00 $1.32 $0.00 $0.00 $0.00 $1.07 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
659.86M 660.32M 553.36M 549.35M 544.56M 542.90M 538.18M 532.63M 531.23M 526.70M 529.10M
Normalized Net Operating Profit after Tax (NOPAT)
-2,192 367 1,131 1,089 1,050 513 1,008 840 1,176 602 1,045
Normalized NOPAT Margin
-34.97% 9.11% 14.13% 17.41% 16.68% 12.75% 16.92% 13.23% 18.05% 9.81% 17.34%
Pre Tax Income Margin
-52.66% 6.76% 15.46% 22.54% 27.34% 11.21% 23.26% 14.55% 17.60% 12.36% 14.56%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
-44.72% -47.44% -47.23% 359.79% 69.16% 62.15% 49.44% 40.27% 45.61% 47.88% 56.38%
Augmented Payout Ratio
-52.40% -47.92% -47.59% 404.06% 94.08% 105.16% 119.21% 131.56% 145.26% 147.55% 198.43%

Financials Breakdown Chart

Key Financial Trends

Here is a concise four-year trend snapshot for 3M Company (MMM) based on the quarterly cash flow, income statement, and balance sheet data provided (covering 2022 through 2025). Key themes include revenue volatility, a late-2025 improvement in cash generation, margin fluctuations, and changes in leverage.

  • 2025 Q3 quarterly revenue reached 6.517 billion, the high-water mark for 2025 and a sign of recovery from earlier years’ softness.
  • 2025 Q3 diluted earnings per share (EPS) was $1.55 and basic EPS was $1.56, marking a strong quarterly profitability peak in 2025.
  • Net cash from continuing operating activities turned positive in 2025 Q3 (about $1.756 billion) and remained positive in 2025 Q4 (about $1.583 billion), signaling improved cash generation.
  • Revenue has shown volatility across the four-year window (notably softer in 2024 versus 2023) with 2025 quarters tending to run in the 6.0–6.5 billion range, suggesting a partial rebound in demand.
  • Cash dividends per share have remained steady around $0.72–$0.73 in 2025, indicating a predictable cash return to shareholders though not a driver of top-line growth.
  • The balance sheet remained solid in 2025, with cash and equivalents around $4.7 billion (Q3) and total assets near $37.6–37.9 billion, providing liquidity headroom.
  • Gross margin compressed in Q4 2025 to roughly 33.5% (about $2.058B gross profit on $6.133B revenue) after stronger margins earlier in the year, signaling cost/mix pressure.
  • 2024 net income to common declined versus 2023 (Q4 2024 net income to common about $0.728B vs. Q4 2023 about $0.945B), highlighting earnings softness during the year.
  • Long-term debt was about $12.5 billion by mid-2025 (Q3 2025 shows long-term debt around $12.477B), indicating modestly higher leverage than a few years earlier.
  • Operating cash flow was negative in Q1 and Q2 2025 (Q1 continuing operating cash flow around -$79 million; Q2 around -$954 million), showing interim cash headwinds during the early-year transition before the late-year improvement.
05/18/26 07:03 AM ETAI Generated. May Contain Errors.

3M Financials - Frequently Asked Questions

According to the most recent income statement we have on file, 3M's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

3M's net income appears to be on a downward trend, with a most recent value of $3.26 billion in 2025, falling from $4.84 billion in 2015. The previous period was $4.19 billion in 2024. Check out 3M's forecast to explore projected trends and price targets.

3M's total operating income in 2025 was $4.63 billion, based on the following breakdown:
  • Total Gross Profit: $9.96 billion
  • Total Operating Expenses: $5.33 billion

Over the last 10 years, 3M's total revenue changed from $30.27 billion in 2015 to $24.95 billion in 2025, a change of -17.6%.

3M's total liabilities were at $32.99 billion at the end of 2025, a 8.3% decrease from 2024, and a 54.0% increase since 2015.

In the past 10 years, 3M's cash and equivalents has ranged from $1.80 billion in 2015 to $5.74 billion in 2023, and is currently $5.24 billion as of their latest financial filing in 2025.

Over the last 10 years, 3M's book value per share changed from 18.56 in 2015 to 8.85 in 2025, a change of -52.3%.



Financial statements for NYSE:MMM last updated on 4/23/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners